Results
T2D
MINOR
Initially, we invited 105 people with T2D to take part in the study. We did not have success with the strategy to include additional patients from the clinics that at this timepoint were in a lock-down situation because of the COVID-19 restrictions. Thus, the anticipated effects of implementing mitigating strategies leading to an inclusion of a type of participants to the trial with more specific health challenges than described in the protocol did not appear. Participants had a mean age of 63.5 years (SD 10.54), 51.3% (n = 39) were men, 24.3% (n = 18) were living alone, 31.6% (n = 24) worked full-time and 44.7% (n = 34) were retired, with minor differences between the groups (